T-lymphocyte-directed gene therapy für ADA-SCID: initial trial results after 4 years; severe combined immunodeficiency therapy by adenosine-deaminase gene transfer using a retrovirus vector. - Blaese,R.M.; Culver,K.W.; Miller,A.D.; Carter,C.S.; Fleisher,T.; Clerici,M.; Shearer,G.; Chang,L.; Chiang,Y.; Tolstoshev,P.; Greenblatt,J.J.; Rosenberg,S.A.; et al. (Science, 1995)